-
Mashup Score: 1Letter #167: Sergio Marchionne (2015) - 1 month(s) ago
Chairman and CEO of Ferrari and CEO of Fiat Chrysler Automobiles | Confessions of a Capital Junkie: An insider perspective on the cure for the industry’s value-destroying addiction to capital
Source: aletteraday.substack.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 1glenmark cancer drug: Glenmark gets USFDA nod to begin trials for potential cancer drug - The Economic Times - 1 year(s) ago
The USFDA approval paves the way for Glenmark’s subsidiary Glenmark Specialty to proceed with a Phase 1/2, first-in-human, clinical study of GRC 54276 for the treatment of patients with advanced solid tumors and lymphomas.
Source: m.economictimes.comCategories: Latest Headlines, Oncologists2Tweet-
Glenmark cancer drug: Glenmark gets USFDA nod to begin trials for potential cancer drug . Proud to be part of this team. One more step towards making life better. Thanks to patients and numerous individuals. https://t.co/CGFrKfoHnN
-
-
Mashup Score: 0
Pharmaceutical companies are using recent advances in digital technologies to improve care strategies and provide hope for rare disease patients across thousands of different rare diseases.
Source: McKinsey & CompanyCategories: Latest Headlines, Oncologists2Tweet-
Treating rare diseases: How digital technologies can drive innovation | McKinsey https://t.co/OYRNrLNmbm
-
-
Mashup Score: 0
A natural language model has jumpstarted the process of protein design by creating active enzymes. Researchers have developed an AI system that can generate artificial enzymes from scratch. In laboratory experiments, some of these enzymes demonstrated efficacy comparable to natural enzymes, even wh
Source: SciTechDailyCategories: Latest Headlines, Oncologists2Tweet-
The language model is learning aspects of evolution, but it’s different than the normal evolutionary process,” We now have the ability 2 tune the generation of these properties 4 specific effects. 4 eg enzyme that’s incredibly thermostable or likes acidic https://t.co/o1c3PvDA7a
-
-
Mashup Score: 0CANcer Distributed Learning Environment (CANDLE) | CBIIT - 1 year(s) ago
CANDLE is an open source, collaboratively developed software platform that provides deep learning methodologies for accelerating cancer research.
Source: datascience.cancer.govCategories: Latest Headlines, Oncologists2Tweet-
CANcer Distributed Learning Environment (CANDLE) | CBIIT An open source platform to help cancer research #cancer #research https://t.co/BKCFi2VoPs
-
-
Mashup Score: 0How Microsoft Became Innovative Again - 1 year(s) ago
How did Microsoft revive its culture of innovation? For years, the company has been written off for playing defense on its position in the tech world. But, as signaled by its partnership with OpenAI and its challenge to Google’s search supremacy, it has gone back on the offense. The about face was, at its core, a cultural shift, driven by CEO Satya Nadella. He drove this by inviting an…
Source: Harvard Business ReviewCategories: Latest Headlines, Oncologists2Tweet-
Microsoft Became Innovative Again You don’t need to be a tech company — we’ve seen similar shifts in industries such as retail and manufacturing. But you have to resolve to go on offense, with an existential commitment, a startup mindset, and bold action https://t.co/idDakYrzWI
-
-
Mashup Score: 0
Scientists are deciphering how the brain choreographs immune responses, hoping to find treatments for a range of diseases.
Source: www.nature.comCategories: Latest Headlines, Oncologists2Tweet-
Disclaimer : Mice data and much of the research quoted is still work in progress . But a fascinating peek into understanding the mind body connection. Immune system modulation by brain & vagus nerve. Heart disease , cancer , autoimmune disorders- think https://t.co/qHolVvbBe7
-
-
Mashup Score: 0Number One in Formula One - 1 year(s) ago
Toto Wolff, the team principal for Mercedes-AMG Petronas—arguably the most impressive team in F1 racing history—has led his organization to unparalleled success. Mercedes earned the Constructors’ Championship (for best overall team performance) every year from 2014 through 2021, and over that time frame it won nearly 70% of the Grand Prix races it competed in. To understand what made that…
Source: Harvard Business ReviewCategories: Latest Headlines, Oncologists2Tweet-
Number One in Formula One -Lessons for all “It is not necessarily the best individuals who win races but the team that works best together.” https://t.co/f5MSLfEPih
-
-
Mashup Score: 0No-label quality goods - 1 year(s) ago
The story of a brand that created a strong identity without trying to be omnipresent or loud.
Source: daily.stoa.comCategories: Latest Headlines, Oncologists2Tweet-
No-label quality goods “MUJI products earned the support of consumers, who are highly conscious of their living environment, and of opinion leaders, with their sophisticated perception.” https://t.co/pVoCkg8u6U
-
-
Mashup Score: 0
Iatrogenics is when we cause more harm by intervention than we do good. interventionistas do because they 1) are unable to think through problems, 2) are separated from the outcomes, 3) are biased for action, and 4) have asymmetric upside.
Source: Farnam StreetCategories: Latest Headlines, Oncologists2Tweet-
Iatrogenics: Why Intervention Often Leads to Worse Outcomes - Farnam Street https://t.co/9HnWOdUXKQ
-
Can apply to biotech and pharma too ! Letter #167: Sergio Marchionne (2015), by @kevg1412 https://t.co/QfVRvBl5LQ